Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

ITF2357, a Novel Histone-Deacetylase Inhibitor, Is Effective against Peripheral T-Cell Lymphomas in Vivo

Pier Paolo Piccaluga, Maura Rossi, Aurora Esposito, Pier Luigi Tazzari, Francesca Ricci, Giordano Nicoletti, Lorena Landuzzi, Stefano Fanti, Valentina Ambrosini, Flavio Leoni, Paolo Mascagni, Anna Gazzola, Pier Luigi Lollini, Pier Luigi Zinzani, Stefano A. Pileri

Blood (2008) 112 (11): 4981.

https://doi.org/10.1182/blood.V112.11.4981.4981

Published: 2008

Journal Articles

The AKT Inhibitor, A443654, Induces Cell Cycle Arrest, Apoptosis and Synergizes with Chemotherapeutic Drugs in Multi-Drug Resistant T-Cell Acute Lymphoblastic Leukemia - A Novel Agent for Therapy of Drug Resistant ALL.

James A. McCubrey, PhD, William L. Blalock, PhD, Pier Luigi Tazzari, MD, Alessandra Cappellini, PhD, Ilaria Iacobucci, PhD, Francesca Chiarini, BS, Steve L. Abrams, BS, Emanuela Ottaviani, PhD, Giovanni Martinelli, MD, Agostino Tafuri, MD, Lucio Cocco, MD PhD, Alberto M. Martelli, MD PhD, Federica Fala, MD

Blood (2007) 110 (11): 3344.

https://doi.org/10.1182/blood.V110.11.3344.3344

Published: 2007

Journal Articles

The Novel Akt Inhibitor Perifosine Induces Apoptosis, Cell Cycle Arrest and Synergizes with Chemotherapeutic Drugs in Acute Myelogenous Leukemia Cells by a JNK Dependent Mechanism - A Novel Therapeutic Approach for Leukemia Displaying Elevated Akt Signaling.

Alberto M. Martelli, MD, PhD, Veronica Papa, BS, Pier Luigi Tazzari, MD, Francesca Chiarini, BS, Alessandra Cappellini, PhD, Francesca Ricci, BS, Anna Maria Billi, PhD, Camilla Evangelisti, PhD, Steve L. Abrams, BS, Emanuela Ottaviani, PhD, Giovanni Martinelli, MD, James A. McCubrey, PhD

Blood (2007) 110 (11): 3355.

https://doi.org/10.1182/blood.V110.11.3355.3355

Published: 2007

Journal Articles

A New Abl Kinase Inhibitor (AMN107) Has In Vitro Activity on Chronic Myeloid Leukaemia (CML) Ph+ Cells Resistant to Imatinib.

Giovanni Martinelli, Alberto M. Martelli, Tiziana Grafone, Irina Mantovani, Alessandra Cappellini, Pier Luigi Tazzari, Emanuela Ottaviani, Simona Soverini, Marilina Amabile, Matteo Renzulli, Carolina Terragna, Sabrina Colarossi, Ilaria Iacobucci, Angela Poerio, Michele Baccarani

Blood (2005) 106 (11): 2004.

https://doi.org/10.1182/blood.V106.11.2004.2004

Published: 2005

Journal Articles

Frequent Elevation of Akt Kinase Phosphorylation in Mononuclear Cells from High-Risk Myelodysplastic Syndrome Patients.

Costanza Bosi, MD, Carlo Finelli, MD, Alberto M. Martelli, MD, Maria Nyakern, Ph.D., Giovanni Martinelli, MD, Pier Luigi Tazzari, MD, Lucio Cocco, MD, Tiziana Grafone, PhD, Pier Paolo Piccaluga, MD, Baccarani Michele, MD

Blood (2005) 106 (11): 3432.

https://doi.org/10.1182/blood.V106.11.3432.3432

Published: 2005

Journal Articles

A New Abl Kinase Inhibitor (AMN107) Has In Vitro Activity on CML Ph+Blast Cells Resistant to Imatinib.

Giovanni Martinelli, Alberto M. Martelli, Tiziana Grafone, Gianantonio Rosti, Irina Mantovani, Alessandra Cappellini, Pier Luigi Tazzari, Emanuela Ottaviani, Matteo Renzulli, Marilina Amabile, Angela Poerio, Simona Soverini, Carolina Terragna, Cristian Taccioli, Simona Bassi, Michele Baccarani

Blood (2004) 104 (11): 4687.

https://doi.org/10.1182/blood.V104.11.4687.4687

Published: 2004

Journal Articles

Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells

Elena Tenedini, Maria Elena Fagioli, Nicola Vianelli, Pier Luigi Tazzari, Francesca Ricci, Enrico Tagliafico, Paolo Ricci, Luigi Gugliotta, Giovanni Martinelli, Sante Tura, Michele Baccarani, Sergio Ferrari, Lucia Catani

Blood (2004) 104 (10): 3126–3135.

https://doi.org/10.1182/blood-2003-07-2597

Published: 2004

Includes: Supplemental data

Journal Articles

CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells

Maria Pia Pistillo, Pier Luigi Tazzari, Giulio Lelio Palmisano, Ivana Pierri, Andrea Bolognesi, Francesca Ferlito, Paolo Capanni, Letizia Polito, Marina Ratta, Stefano Pileri, Milena Piccioli, Giuseppe Basso, Laura Rissotto, Roberto Conte, Marco Gobbi, Fiorenzo Stirpe, Giovanni Battista Ferrara

Blood (2003) 101 (1): 202–209.

https://doi.org/10.1182/blood-2002-06-1668

Published: 2003

NARROW

ITF2357, a Novel Histone-Deacetylase Inhibitor, Is Effective against Peripheral T-Cell Lymphomas in Vivo

The AKT Inhibitor, A443654, Induces Cell Cycle Arrest, Apoptosis and Synergizes with Chemotherapeutic Drugs in Multi-Drug Resistant T-Cell Acute Lymphoblastic Leukemia - A Novel Agent for Therapy of Drug Resistant ALL.

The Novel Akt Inhibitor Perifosine Induces Apoptosis, Cell Cycle Arrest and Synergizes with Chemotherapeutic Drugs in Acute Myelogenous Leukemia Cells by a JNK Dependent Mechanism - A Novel Therapeutic Approach for Leukemia Displaying Elevated Akt Signaling.

A New Abl Kinase Inhibitor (AMN107) Has In Vitro Activity on Chronic Myeloid Leukaemia (CML) Ph+ Cells Resistant to Imatinib.

Frequent Elevation of Akt Kinase Phosphorylation in Mononuclear Cells from High-Risk Myelodysplastic Syndrome Patients.

A New Abl Kinase Inhibitor (AMN107) Has In Vitro Activity on CML Ph+Blast Cells Resistant to Imatinib.

Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells

CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only